# Propafenone Versus Amiodarone in Septic Shock

> **NCT03029169** · PHASE4 · COMPLETED · sponsor: **Charles University, Czech Republic** · enrollment: 210 (actual)

## Conditions studied

- Supraventricular Arrhythmia
- Septic Shock

## Interventions

- **DRUG:** Propafenone i.v.
- **DRUG:** Amiodarone i.v.

## Key facts

- **NCT ID:** NCT03029169
- **Lead sponsor:** Charles University, Czech Republic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-23
- **Primary completion:** 2022-07-04
- **Final completion:** 2022-08-01
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2022-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03029169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03029169, "Propafenone Versus Amiodarone in Septic Shock". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03029169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*